|
| Home | ● | Contact | ● | Sanquin | ● | News | ● | Jobs | ● | Sitemap | ● |
| Annual reports |
|
Conferences
|
| Press releases |
| Theses |
|
Publications
|
|
Exhibitions
|
| Spring Seminars |
Press releases
| Sanquin Blood Supply Foundation and the Netherlands Cancer Institute winners of the Amsterdam Inventor Award 2010 (Amsterdam, 17 June 2010) Sanquin Blood Supply Foundation (Sanquin) and the Netherlands Cancer Institute (NKI-AVL) as a team are the winners of the 2010 Amsterdam Inventor Award for their inventions addressing 'T cell Epitope Selection and Monitoring'. The winners have been made public at the Amsterdam Inventor Dinner last June 10th. Read on AmpVacs a broadly protective synthetic influenza A vaccine (Amsterdam, 2 March 2010) Sanquin Blood Supply Foundation, the Netherlands Cancer Institute, and the Netherlands Vaccine Institute announce today the launch of their joint AmpVacs project aiming at the development of a broadly protective synthetic influenza A vaccine component that in combination with classical antibody-stimulating vaccines will induce protection against future influenza A threats. Read on Sanquin’s transferrin shows positive results in β-thalassaemia disease model (Amsterdam, 25 January 2010) In an animal model of ß-thalassaemia, transferrin has been shown to have a positive effect on several of the clinical parameters normally affected in ß -thalassaemia in man: it increased hemoglobin levels, normalized red blood cell survival and reduced the enlargement of the spleen. Read on |